Skip to content

Pathways to Prevention (Protocol TN-01)

Type 1 Diabetes | Diabetes

This study will help us learn more about how type 1 diabetes occurs as well as help us to identify people who may be eligible for prevention trials through screening. By ongoing monitoring, we will compare people with and without auto-antibodies to help us better understand differences over time.

null

Conditions de participation

  • Sexe:

    Male, Female, Intersex

  • Âges admissibles:

    2 to 45

Critères de participation

Inclusion Criteria:
- 2 to 45 years old and have a brother, sister, child, or parent with type 1 diabetes.
- 2 to 20 years old and have a cousin, aunt, uncle, niece, nephew, half-brother, half-sister, or grandparent with type 1 diabetes.
- Individuals (age 2 years - 45 years) who have diabetes related autoantibodies found though external screening

Exclusion Criteria:
Individuals with Type 1 diabetes

Lieu de l'étude

University of Calgary
University of Calgary
Calgary, Alberta
Canada

Contactez l'équipe d'étude

Étude parrainée par
University of Calgary
Participants recherchés
Plus d'informations
ID de l'étude: REB14-2465